• 1.

    King M. Stem cell therapy. The Horse 2006;Jun. Available at: www.thehorse.com. Accessed Apr 10, 2008.

  • 2.

    US Department of Health and Human Services, National Institutes of Health Web site. Stem cell basics: what are adult stem cells? Available at: stemcells.nih.gov/info/basics/basics4. Accessed Apr 10, 2008.

  • 3.

    AVMA Web site. Position statements: stem cells. Available at: www.avma.org/issues/policy/stem_cells.asp. Accessed Apr 10, 2008.

  • 4.

    Vet-Stem Web site. Available at: www.vet-stem.com. Accessed Apr 10, 2008.

  • 5.

    Vet Cell Web site. Available at: www.vetcell.com. Accessed Apr 10, 2008.

  • 6.

    Vet Biotechnology Web site. Available at: www.vetbiotechnology.com.au. Accessed Apr 10, 2008.

  • 7.

    Pinock S. Stem cells in racehorses. Scientist 2005;19:34.

  • 8.

    Salleh A. Stem cells may keep racehorses on track. ABC Science Online 2005;Nov 11. Available at: www.abc.net.au/science/news/stories/s1501332.htm. Accessed Apr 10, 2008.

    • Search Google Scholar
    • Export Citation
  • 9.

    Smith Thomas H. Health notes: stem cell therapy holds promise for injured tendons and ligaments. Mid-Atlantic Thoroughbred 2004;May:7071.

    • Search Google Scholar
    • Export Citation
  • 10.

    Smith Thomas H. Stem cell therapy for repairing tendons and ligaments. California Thoroughbred 2004;Jun:51, 54, 55.

  • 11.

    Clegg P. Stem cells—hope or hype? Horse & Hound 2005;Jul:1213.

  • 12.

    Federal Food, Drug, and Cosmetic Act, 21 USC §301–399.

  • 13.

    Public Health Service Act, 42 USC §262, 264, 266.

  • 14.

    Human Cells, Tissues, and Cellular and Tissue-Based Products Regulations, 21 CFR §1271.1–1271.440; Drug for Human Use, 21 CFR §300–369; Medical Devices, 21 CFR §800–898.

    • Search Google Scholar
    • Export Citation
  • 15.

    Public Health Service Act, 42 USC §262(a)(1)–(a)(2)(C).

  • 16.

    21 CFR §1271.3(d).

  • 17.

    21 CFR §1271.160–1271.320.

  • 18.

    21 CFR §1271.145–1271.320.

  • 19.

    21 CFR §1271.10(b).

  • 20.

    21 CFR §1271.3(f)(1)–(2).

  • 21.

    21 CFR §1271.10(a)(2).

  • 22.

    21 CFR §1271.20.

  • 23.

    21 USC §355.

  • 24.

    Virus, Serum, and Toxin Act of 1913, 21 USC §151–158.

  • 25.

    Food, Drug, and Cosmetic Act, 21 USC §354 (Veterinary Feed Directive Drugs); 21 USC §360b (New Animal Drugs); 21 USC §360ccc (New Animal Drugs for Minor Use and Minor Species); 21 USC §379j (Fees Relating to Animal Drugs).

  • 26.

    21 USC §151–158. See also United States v Miami Serpentarium Laboratories Inc, Food, Drug, Cosm L rep (CCH) [1982–83] Dev Trans Binder 38, 164 (SD Fla, 1982).

  • 27.

    21 USC §155.

  • 28.

    21 USC §355; 21 USC §360b.

  • 29.

    Grand Laboratories Inc v Harris, 660 F2d 1288 (8th Cir, 1981).

  • 30.

    AVMA Web site. AVMA guidelines for complementary and alternative veterinary medicine. Available at: www.avma.org/issues/policy/comp_alt_medicine.asp. Accessed Mar 20, 2008.

  • 31.

    AVMA adopts policy on informed consent. J Am Vet Med Assoc 2007;230:1435.

  • 32.

    21 USC §360b(a)(1).

  • 33.

    United States v Evers, 643 F2d 1043 (5th Cir, 1981).

  • 34.

    Richardson LE, Dudhia J, Clegg PD, et al. Stem cells in veterinary medicine—attempts at regenerating equine tendon after injury. Trends Biotechnol 2007;9:409416.

    • Search Google Scholar
    • Export Citation
  • 35.

    Herthel DJ. Enhanced suspensory ligament healing in 100 horses by stem cells and other bone marrow components, in Proceedings. Am Assoc Equine Pract Annu Meet 2001;47:319321.

    • Search Google Scholar
    • Export Citation

Advertisement

Regulatory considerations related to stem cell treatment in horses

Gary L. YinglingKirkpatrick & Lockhart Preston Gates Ellis LLP, 1601 K St NW, Washington, DC 20006.

Search for other papers by Gary L. Yingling in
Current site
Google Scholar
PubMed
Close
and
Karl M. NobertKirkpatrick & Lockhart Preston Gates Ellis LLP, 1601 K St NW, Washington, DC 20006.

Search for other papers by Karl M. Nobert in
Current site
Google Scholar
PubMed
Close

Contributor Notes

Address correspondence to Dr. Nobert.